Results 181 to 190 of about 405,002 (265)
Plasma Membrane Remodeling During Microglial Activation: A Hypothesis Linking Microglial Shape and Lipid Droplet Formation. [PDF]
Rebeck GW +4 more
europepmc +1 more source
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng +4 more
wiley +1 more source
Longitudinal Evaluation of <sup>18</sup>F-MK-6240 Along the Alzheimer Disease Continuum. [PDF]
Giarratana AO +8 more
europepmc +1 more source
ATP itself is able to undergo liquid–liquid phase separation in the presence of the macromolecular crowding agent PEG and physiological ATP concentrations are sufficient for phase separation in the presence of mM Mg2+ and crowders, mimicking intracellular conditions.
Robert Dec +2 more
wiley +1 more source
Raman Optical Activity as a Tool to Monitor Polynucleotide Conformation in Solutions
Raman optical activity (ROA) studies of nucleic acids have been hindered by limited computational tools to link the spectra to the structure. The study shows that accurate density functional simulations are possible for model nucleotides, bringing more information about molecular geometry and dynamics in solutions.
Mohammed Siddhique Para Kkadan +5 more
wiley +1 more source
Site-Specific Raman Probes Reveal Droplet Aging and Residue-Level Fibril Polymorphism in TDP-43<sub>CTD</sub>. [PDF]
Watson MD, Lee JC.
europepmc +1 more source
Fibrilpaint: A Class of Amyloid‐Targeting Peptides
FibrilPaints are modular peptides engineered to recognize amyloid fibrils. By systematically varying charge, sequence, and termini, their binding behavior can be tuned while retaining recognition. Successful binding ″paints″ fibrils for visualization and opens routes toward targeted degradation and diagnostic applications.
Júlia Aragonès Pedrola +8 more
wiley +1 more source
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change. [PDF]
Burkett BJ +16 more
europepmc +1 more source

